On Assignment (ASGN) has been under a strong bear grip, hence the stock is down -6.54% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 3.01% in the past 1 week. The stock has risen by 2.98% in the past week indicating that the buyers are active at lower levels, but the stock is down -6.19% in the past 4 weeks.
On Assignment Inc. is up 0.21% in the last 3-month period. Year-to-Date the stock performance stands at -17%. The stock has recorded a 20-day Moving Average of 1.15% and the 50-Day Moving Average is 0.69%.
On Assignment (NYSE:ASGN): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $36.92 and $36.84 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $37.43. The buying momentum continued till the end and the stock did not give up its gains. It closed at $37.31, notching a gain of 0.81% for the day. The total traded volume was 209,472 . The stock had closed at $37.01 on the previous day.
Also, Deutsche Bank initiates coverage on On Assignment (NYSE:ASGN). The current rating of the shares is Buy, according to the research report released by the firm. The rating by the firm was issued on August 18, 2016.
On Assignment, Inc. is a global provider of professionals in the information technology (IT), engineering and life sciences sectors. The Company matches people into positions for contract, contract-to-hire and direct hire assignments. Its operating segments include Apex, Oxford and Life Sciences Europe. The Apex Segment provides information technology and scientific staffing professionals for contract, contract-to-hire and permanent placement positions. The Oxford Segment provides contract and direct placement services of information technology and engineering professionals in specialized information technology, software and hardware engineering, and mechanical, electrical, validation and telecommunications engineering fields. The Life Sciences Europe Segment provides locally-based contract life science professionals to clients in the biotechnology, pharmaceutical, food and beverage, medical device, personal care, chemical, automotive, educational and environmental industries.